Journals / Göztepe Tıp Dergisi / 2012 / Cilt: 27 - Sayı: 3

Sarcoidosis with systemic hypertension: Case report

Sistemik hipertensiyon ile başvuran sarkoidoz olgusu: Olgu takdimi

Pages
119–123
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

His arterial blood pressure and calcium level were 220/110 mmHg, and 17.4 mg/dl, respectively, and histopathological evaluation after splenectomy confirmed the diagnosis of sarcoidosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Sarcoidosis, which occurs often with the lung involvement and causes significant morbidity, is a multisystem granulomatous disease.
📊
Key Findings & Data:However, systemic hypertension secondary to hypercalcemia is very rare.We present a 29-year old male patient admitted to the emergency service with complaints of headache and nausea.
💡
Conclusion & Impact:His arterial blood pressure and calcium level were 220/110 mmHg, and 17.4 mg/dl, respectively, and histopathological evaluation after splenectomy confirmed the diagnosis of sarcoidosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Sarcoidosis, which occurs often with the lung involvement and causes significant morbidity, is a multisystem granulomatous disease. This disease manifests itself with signs, and symptoms of neurological disease such as uveitis, blindness or end-stage pulmonary fibrosis, pulmonary hypertension, dysrhythmias, cardiomyopathy, hypercalcemia and renal insufficiency. However, systemic hypertension secondary to hypercalcemia is very rare.We present a 29-year old male patient admitted to the emergency service with complaints of headache and nausea. His arterial blood pressure and calcium level were 220/110 mmHg, and 17.4 mg/dl, respectively, and histopathological evaluation after splenectomy confirmed the diagnosis of sarcoidosis.

Özet

Sarkoidoz , sıklıkla akciğerleri tutan ve önemli morbiditeyeneden olan multisistem granülomatöz bir hastalıktır. Bu hastalıknörolojik bir hastalık olarak kendini gösterebileceği gibiuveitis, körlük, son dönem pulmoner fibrosis, pulmoner hipertansiyon,disritmiler, kardiyomyopati, hiperkalsemi ve renalyetmezlik bulguları ile de karşımıza çıkabilir. Bununla birlikte,hiperkalsemiye sekonder sistemik hipertansiyon çok nadirdir.Biz de baş ağrısı ve bulantı şikayetleriyle hastanemiz acil servisinebaşvuran 29 yaşındaki erkek hastanın yapılan değerlendirmelerindearteriyel kan basıncı 220/110 mmHg ve kalsiyum17.4 mg/dl ile splenektomi sonrası patoloji raporunda sarkoidozsaptanan olguyu sunacağız.

🔖

Cite This Article

ÇALAN, M., BİLGİR, O., OZTEKİN, O., CANBOLAT, S., BALIKÇI, O., BİLGİR, F. (2022). Sarcoidosis with systemic hypertension: Case report. Göztepe Tıp Dergisi, Cilt: 27 - Sayı: 3, 119–123. https://ajindex.com/articles/526091

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357(21):2153-2165. http://dx.doi.org/10.1056/NEJMra071714 PMid:18032765 2. Chen ES, Song Z, Willett MH, et al. Serum amyloid A regulates granulomatous inflammation in sarcoidosis through toll-like receptor-2. Am J Respir Crit Care Med 2010;181(4):360-373. http://dx.doi.org/10.1164/rccm.200905-0696OC PMid:19910611 PMCid:2822973 3. Müller-Quernheim J, Schürmann M, Hofmann S, et al. Genetics of sarcoidosis. Clin Chest Med 2008;29(3):391- 414. http://dx.doi.org/10.1016/j.ccm.2008.03.007 PMid:18539234 4. Song Z, Marzilli L, Greenlee BM, et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 2005;201(5):755-767. http://dx.doi.org/10.1084/jem.20040429 PMid:15753209 PMCid:2212832 5. Co DO, Hogan LH, Il-Kim S, Sandor M. T cell contributions to the different phases of granuloma formation. Immunol Lett 2004;92(1-2):135-142. http://dx.doi.org/10.1016/j.imlet.2003.11.023 PMid:15081537 6. Chen ES, Moller DR. Etiology of sarcoidosis. Clin Chest Med 2008;29(3):36. http://dx.doi.org/10.1016/j.ccm.2008.03.011 PMid:18539232 7. Statement on sarcoidosis: Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160(2):736-755. PMid:10430755 8. Pinkston P, Bitterman PB, Crystal RG. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med 1983;308(14):793- 800. http://dx.doi.org/10.1056/NEJM198304073081401 PMid:6601235 9. Robinson BW, McLemore TL, Crystal RG. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 1985;75(5):1488-1495. http://dx.doi.org/10.1172/JCI111852 PMid:3923038 PMCid:425487 10. Shigehara K, Shijubo N, Ohmichi M, et al. IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J Immunol 2001;166(1):642-649. PMid:11123348 11. Agostini C, Meneghin A, Semenzato G. T-lymphocytes andcytokines in sarcoidosis. Curr Opin Pulm Med 2002;8(5):435-440. http://dx.doi.org/10.1097/00063198-200209000-00016 PMid:12172449 12. Chan ES, Cronstein BN. Molecular action of methotrexate in inflammatory diseases. Arthritis Res 2002;4(